Abstract:Background: Gene expression-based subtyping has the potential to form a new paradigm for stratified treatment of colorectal cancer. However, current frameworks are based on the transcriptomic profiles of primary tumors, and metastatic heterogeneity is a challenge. Here we aimed to develop a de novo metastasis-oriented framework. Methods: In total, 829 transcriptomic profiles from patients with colorectal cancer were analyzed, including primary tumors, liver metastases, and non-malignant liver samples. High-resolution microarray gene expression profiling was performed of 283 liver metastases from 171 patients treated by hepatic resection, including multiregional and/or multi-metastatic samples from each of 47 patients. A single randomly selected liver metastasis sample from each patient was used for unsupervised subtype discovery by nonnegative matrix factorization, and a random forest prediction model was trained to classify multi-metastatic samples, as well as liver metastases from two independent series of 308 additional patients. Results: Initial comparisons with non-malignant liver samples and primary colorectal tumors showed a highly variable degree of influence from the liver microenvironment in metastases, which contributed to inter-metastatic transcriptomic heterogeneity, but did not define subtype distinctions. The de novo liver metastasis subtype (LMS) framework recapitulated the main distinction between epithelial-like and mesenchymal-like tumors, with a strong immune and stromal component only in the latter. We also identified biologically distinct epithelial-like subtypes originating from different progenitor cell types. LMS1 metastases had several transcriptomic features of cancer aggressiveness, including secretory progenitor cell origin, oncogenic addictions, and microsatellite instability in a microsatellite stable background, as well as frequent RAS/TP53 co-mutations. The poor-prognostic association of LMS1 metastases was independent of mutation status, clinicopathological variables, and current subtyping frameworks (consensus molecular subtypes and colorectal cancer intrinsic subtypes). LMS1 was also the least heterogeneous subtype in comparisons of multiple metastases per patient, and tumor heterogeneity did not confound the prognostic value of LMS1. Conclusions: We report the first large study of multi-metastatic gene expression profiling of colorectal cancer. The new metastasis-oriented subtyping framework showed potential for clinically relevant transcriptomic classification in the context of metastatic heterogeneity, and an LMS1 mini-classifier was constructed to facilitate prognostic stratification and further clinical testing.

Transcriptomic Maps of Colorectal Liver Metastasis: Machine Learning of Gene Activation Patterns and Epigenetic Trajectories in Support of Precision Medicine

Transcriptome analysis of colorectal cancer liver metastasis: The importance of long non-coding RNAs and fusion transcripts in the disease pathogenesis

Using machine learning approach for screening metastatic biomarkers in colorectal cancer and predictive modeling with experimental validation

Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis

Integrative genomic and transcriptomic characterization of matched primary and metastatic liver and colorectal carcinoma.

Construction of a co-expression network and prediction of metastasis markers in colorectal cancer patients with liver metastasis

Machine learning-based screening and validation of liver metastasis-specific genes in colorectal cancer

Differences in genome, transcriptome, miRNAome, and methylome in synchronous and metachronous liver metastasis of colorectal cancer

High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome

Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer

Identification of novel diagnostic biomarkers associated with liver metastasis in colon adenocarcinoma by machine learning

Proteomics and liquid biopsy characterization of human EMT-related metastasis in colorectal cancer

Genomic characterization of liver metastases from colorectal cancer patients

Microarray Analyses Reveal Liver Metastasis-Related Genes in Metastatic Colorectal Cancer Cell Model.

Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis

Molecular insights into the development of hepatic metastases in colorectal cancer: a metastasis prediction study

Chromatin accessibility dynamics in colorectal cancer liver metastasis: Uncovering the liver tropism at single cell resolution

De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity

Multi-omics Analysis Classifies Colorectal Cancer into Distinct Methylated Immunogenic and Angiogenic Subtypes Based on Anatomical Laterality

Genomic Analysis Identifies Unique Signatures Predictive of Brain, Lung, and Liver Relapse

A radiomics and genomics-derived model for predicting metastasis and prognosis in colorectal cancer